{'text': 'Achillion, Johnson & Johnson Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead and AbbVie', 'publisher': {'href': 'https://www.biospace.com', 'title': 'BioSpace'}, 'created_at': 'Tue, 19 May 2015 07:00:00 GMT', 'description': 'Achillion, Johnson & Johnson Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead and AbbVie  BioSpace', 'url': 'https://news.google.com/rss/articles/CBMixwFBVV95cUxPNUxCOXJBYl9IODFmUk0zUVVtaEpHbGFFMERLb0NDTzdPV0drNGdaVTNDRm5yN2RPd1BfTThYNDdxMWNrMjNreEs2dmZHSVFFR3Y3NElrZVlsb2diUmF5U3FqS2VsN3R0NVR3T1V4czh0alRkUm5CS2dMQi1BYVdsN19la0pyXzR1UFRzVVhUV1BzQjR3Q3pUUU1QU1BsQU1MczljeExzOWtUSnhlZHh0Y3BVNHNjRlo3MmdvWk1adTVVNG1XelZj?oc=5&hl=en-US&gl=US&ceid=US:en'}
